An open up-label study was performed in 2016 in the UK to analyze the feasibility, safety and efficacy of psilocybin in treating individuals with unipolar treatment-resistant depression with promising outcomes; Even though the study was compact and involved only twelve patients, 7 of These clients met formal requirements for remission https://buypsilocybinextractonlin86576.verybigblog.com/32620756/the-greatest-guide-to-how-to-take-psychedelics-safely